One of the possible catalysts that's been withheld from shareholders is the progress of the positive responders in the Australian trials. supposedly, the 6 super responders are still taking the drug and Missling has not unveiled any updates on their progress. To me,as an investor, this is pure dereliction on his part and along with his other missteps is the empirical evidence that he should go.
Market Data 
Markets 
